Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO 2022 | Is there a role for sentinel lymph node biopsy in squamous cell carcinoma?

Antonio Tejera-Vaquerizo • 20 Apr 2022
EADO 2022
Skin Cancer

Antonio Tejera-Vaquerizo, MD, Instituto Dermatológico GlobalDerm, Córdoba, Spain, discusses whether there is a role for sentinel lymph node biopsy (SLNB) in squamous cell carcinoma, highlighting the lack of research and clinical trial data within the field. This interview took place at the EADO 2022 congress.

More from Antonio Tejera-Vaquerizo

The management of squamous cell carcinoma
1:48
The management of squamous cell carcinoma
Antonio Tejera-Vaquerizo • 20 Apr 2022
Prognostic factors of patients with squamous cell carcinoma undergoing a central lymph node biopsy
2:19
Prognostic factors of patients with squamous cell carcinoma undergoing a central lymph node biopsy
Antonio Tejera-Vaquerizo • 20 Apr 2022

Related Videos

BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
1:45
BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
Kalijn Bol • 31 May 2026
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
1:08
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
Kalijn Bol • 31 May 2026
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
1:02
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
Kalijn Bol • 31 May 2026
The future of personalized and off-the-shelf mRNA vaccines in melanoma
1:02
The future of personalized and off-the-shelf mRNA vaccines in melanoma
James Smithy • 31 May 2026
The content of VJOncology is intended for healthcare professionals